Vascular Health and Risk Management

Editor in Chief Professor Roland Asmar

Editorial: Risk of cardiovascular events and cyclooxygenase-2 inhibitors ||FREE PAPER||
Reza Tabrizchi

Clinical implications of angiogenesis in cancers
Roberta WC Pang, Ronnie TP Poon

Endovascular stent-graft placement for vascular failure of the thoracic aorta
Yoshihiko Kurimoto, Kiyofumi Morishita, Yasufumi Asai

A review of Perindopril in the reduction of cardiovascular events
Duncan J Campbell

Valsartan in the treatment of heart attack survivors
Bodh I Jugdutt

The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure
Ovidio De Freitas, Oliver Lenz, Alessia Fornoni, Barry J Materson

Metabolic syndrome, inflammation and atherosclerosis
Rodolfo Paoletti, Chiara Bolego, Andrea Poli, Andrea Cignarella

Lipoprotein-associated phospholipase A2, vascular inflammation and cardiovascular risk prediction
Krishnankutty Sudhir

Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence
Craig S Patch, Linda C Tapsell, Peter G Williams, Michelle Gordon

Leptin and hypertension in obesity
Paco E Bravo, Stephen Morse, David M Borne, Erwin A Aguilar, Efrain Reisin

Vascular risks and management of obesity in children and adolescents
Courtney J Jolliffe, Ian Janssen

Screening for popliteal aneurysms should not be a routine part of a community-based aneurysm screening program
Martin Claridge, Simon Hobbs, Clive Quick, Donald Adam, Andrew Bradbury, Teun Wilmink

Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
Journal Indexing
See where all the Dove Press journals are indexed